Patents by Inventor Martha Jacoba Willemse

Martha Jacoba Willemse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6521236
    Abstract: The present invention is concerned with a Feline Herpesvirus (FHV) mutant comprising a heterologous gene or foreign DNA inserted into a section of the FHV genome. The invention also relates to a vector vaccine comprising a recombinant FHV mutant which expresses a heterologous polypeptide derived from a feline pathogen and a pharmaceutically acceptable carrier and induces an immune response in an inoculated host against both FHV and the feline pathogen.
    Type: Grant
    Filed: July 20, 1995
    Date of Patent: February 18, 2003
    Assignee: Akzo Nobel N.V.
    Inventors: Paulus Jacobus Antonius Sondermeijer, Martha Jacoba Willemse
  • Patent number: 5783192
    Abstract: The present invention is concerned with a Feline herpesvirus (FHV) mutant comprising a heterologous gene introduced into an insertion-region of the FHV genome.The invention also relates to a vector vaccine comprising such an FHV mutant which expresses a heterologous polypeptide derived from a feline pathogen and induces an adequate immune response in an inoculated host against both FHV and the feline pathogen.
    Type: Grant
    Filed: July 17, 1996
    Date of Patent: July 21, 1998
    Assignee: Akzo Nobel N.V.
    Inventors: Martha Jacoba Willemse, Paulus Jacobus Antonius Sondermeijer
  • Patent number: 5674499
    Abstract: The present invention relates to an Equine herpesvirus (EHV) vaccine comprising an EHV having an insertion or deletion in the gene 15 of the EHV genome.
    Type: Grant
    Filed: December 20, 1994
    Date of Patent: October 7, 1997
    Assignee: Akzo Nobel N.V.
    Inventors: Martha Jacoba Willemse, Paulus Jacobus Antonius Sondermeijer, Lesley Nicolson
  • Patent number: 5652119
    Abstract: The present invention is concerned with a Feline herpesvirus (FHV) mutant comprising a heterologous gene introduced into an insertion-region of the FHV genome.The invention also relates to a vector vaccine comprising such an FHV mutant which expresses a heterologous polypeptide derived from a feline pathogen and induces an adequate immune response in an inoculated host against both FHV and the feline pathogen.
    Type: Grant
    Filed: June 19, 1996
    Date of Patent: July 29, 1997
    Assignee: Akzo Nobel N.V.
    Inventors: Martha Jacoba Willemse, Paulus Jacobus Antonius Sondermeijer